Yersinia pseudotuberculosis infection of a lumbar facet joint.
Cormier
Grégoire
G
Lucas
Vincent
V
Varin
Stéphane
S
Hamelin
Jean-Pierre
JP
Tanguy
Gilles
G
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D002443:Ceftriaxone / Q000627:therapeutic use; D006801:Humans; D008159:Lumbar Vertebrae / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D016896:Treatment Outcome; D015011:Yersinia pseudotuberculosis / Q000302:isolation & purification; D015012:Yersinia pseudotuberculosis Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D021801:Zygapophyseal Joint / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D015242:Ofloxacin